Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,612,830
+$807,824 QoQ
Shares Held
22,305
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1,246
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names. ABBV ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,720 | $7,294,018 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
22,305 | $5,612,830 | |
| 3 | LLY |
ELI LILLY & Co
|
4,488 | $5,383,042 | |
| 4 | AMGN |
Amgen Inc
|
14,633 | $5,298,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,306 | $4,022,821 | |
| 6 | PFE |
Pfizer Inc
|
15,983 | $384,870 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,755 | $348,066 | |
| 8 | AZN |
Astrazeneca PLC
|
1,713 | $324,819 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,612,830 | 22,305 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,805,006 | 22,093 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,395,919 | 19,239 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,404,649 | 31,980 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,457,784 | 29,403 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,518,966 | 26,341 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,974,971 | 22,369 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,877,558 | 24,699 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,454,545 | 25,971 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,546,126 | 24,965 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,164,043 | 26,870 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $3,975,132 | 26,668 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,007,139 | 29,742 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,303,627 | 27,004 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,976,737 | 24,607 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,520,866 | 18,783 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,892,579 | 18,886 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $2,981,365 | 18,391 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,626,489 | 19,398 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,060,317 | 19,100 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,049,822 | 18,198 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,921,554 | 17,756 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,855,838 | 17,320 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,463,628 | 16,710 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,742,302 | 17,746 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,316,029 | 17,273 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||